Gater, AdamNelsen, LindaFleming, SarahLundy, J. JasonBonner, NicolaHall, RebeccaMarshall, ChrisStaunton, HannahKrishnan, Jerry A.Stoloff, StuartSchatz, MichaelHaughney, JohnPatient-Reported Outcome Consortium’s Asthma Working Group2016-11-092016-11-092016-06Gater, A, Nelsen, L, Fleming, S, Lundy, J J, Bonner, N, Hall, R, Marshall, C, Staunton, H, Krishnan, J A, Stoloff, S, Schatz, M, Haughney, J & Patient-Reported Outcome Consortium’s Asthma Working Group 2016, 'Assessing Asthma Symptoms in Adolescents and Adults : Qualitative Research Supporting Development of the Asthma Daily Symptom Diary', Value in Health, vol. 19, no. 4, pp. 440-450. https://doi.org/10.1016/j.jval.2016.01.0071098-3015http://hdl.handle.net/2164/7678We thank the members of the US Food and Drug Administration’s Qualification Review Team for their feedback during the development of the ADSD. Source of financial support: Funding for this research was provided by the following PRO Consortium member firms: Actelion; Amgen; AstraZeneca; Boehringer-Ingelheim; Forest Laboratories; Genentech; GlaxoSmithKline; Ironwood Pharmaceuticals; Janssen, Merck, Sharp & Dohme Corp.; Novartis; Pfizer; and Sanofi. In addition, Critical-Path Institute’s PRO Consortium is supported by Critical-Path Public-Private Partnerships (grant no. 1U18FD005320) from the US Food and Drug Administration.111666177engasthmacontent validitypatient-reported outcomessymptomsR MedicineRJournal article10.1016/j.jval.2016.01.007194